SOLARA ACTIVE PHARMA SCIENCES LIMITED — Capital/Financing Update 2025

Apr 2, 2025

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in

April 02, 2025

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Outcome of Rights Issue Committee Meeting dated April 02, 2025

This is to inform you that further to our letter dated March 26, 2025, and pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (‘ SEBI Listing Regulations ’), this is to inform that the Rights Issue Committee of the Board of Directors of the Company at its meeting held today (i.e.) April 02, 2025, inter alia, considered and approved the First Call money Notice, on the partly paid-up Equity Shares issued on Rights basis which is to be sent to the Shareholders

In terms of Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, the Company had fixed Friday, April 04, 2025 to be the Record Date for the purpose of determining the holders of Rights Equity Shares to whom the call notice for the first call will be sent, as already intimated vide our letter dated March 26, 2025.

We request you to take the same on record and the same be treated as compliance under the applicable provisions of the SEBI Listing Regulations, as amended.

The Rights Issue Committee Meeting commenced at 15:00 P.M. and concluded at 15:40 P.M.

Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISH MURALIKRISHNA Date: 2025.04.02 NA 15:44:06 +05'30' S. Murali Krishna Company Secretary & Compliance Officer Membership No.: A13372

Encl.: As above

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address:

Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

Annexure – I

Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read along with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 read with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/ 2023/123 dated July 13, 2023

==> picture [454 x 314] intentionally omitted <==

----- Start of picture text ----- Sr. Particulars RemarksNo.1. Forfeiture of shares Not Applicable.2. Reissue of forfeited shares or Not Applicable.securities, or the issue of shares orsecurities held in reserve for futureissue or the creation in any form ormanner of new shares or securities orany other rights, privileges or benefitsto subscribe to3. Proposal to issue any class of Not Applicablesecurities;4. Alterations of capital, including calls; The first call of ₹ 3.50/- each at a premium of Rs.127.75/- aggregating to ₹157.48 Crores be madeon 1,19,98,755 (One Crore Nineteen LakhsNinety-Eight Thousand Seven hundred and fifty-five) partly paid-up equity shares of the Companyat a face value of Rs. 10/- each.5. Change in the terms regarding Not Applicableredemption/cancellation/retirement inwhole or in part of any securitiesissued by the listed entity----- End of picture text -----

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2025.04.02 15:45:03 +05'30'

S. Murali Krishna Company Secretary & Compliance Officer Membership No.: A13372

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942